Visceral Leishmaniasis presenting with Hemophagocytosis and Myelodysplasia: A Case report and review of the literature
Jennifer Kaivers4, Annika Kasprzak1, Norbert Gattermann1, Björn-Erik Ole Jensen2, Martha Holtfreter 2, Martina Rudelius 3, Ulrich Germing1
1Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Germany,
2Department of Gastroenterology, Hepatology and Infectiology, University Hospital Düsseldorf, Germany
3Institute of Pathology, LM University München, Germany
4Department of Hematology and Hematopoietic Stem Cell Transplantation, University Hospital Essen, Germany
*Corresponding author
*Annika Kasprzak, MD, Department of Hematology, Oncology, and Clinical Immunology, Heinrich-HeineUniversity, Düsseldorf, Germany
DOI: 10.55920/JCRMHS.2023.03.001121
Figure 1: Dysplastic erythropoiesis leading to the suspected diagnosis of MDS
Figure 2: Leishmania (red circle) in a bone marrow smear finally leading to the diagnosis of visceral leishmaniasis
- Ready PD. Epidemiology of visceral leishmaniasis. Clin Epidemiol. 2014 May 3;6:147-54.
- German Society for Tropical Medicine and International Health. Guidelines: Diagnostic and treatment of visceral leishmaniasis (Kala-Azar) (Version November 2016)
- WORLD HEALTH ORGANIZATION, et al. Control of the leishmaniases: report of a meeting of the WHO expert committee on the control of leishmaniases. In: Control of the leishmaniases: report of a meeting of the WHO expert committee on the control of leishmaniases. World Health Organization, 2010.
- Pace D. Leishmaniasis. J Infect. 2014 Nov;69 Suppl 1:S10-8.
- Granert C, Elinder G, Ost A, Henter JI. Kala-azar in a one-year-old Swedish child. Diagnostic difficulties because of active hemophagocytosis. Acta Paediatr. 1993 Sep;82(9):794-6.
- Ayako Morimoto, Satoko Omachi, Yasutaka Osada, James K. Chambers, Kazuyuki Uchida, Chizu Sanjoba, Yoshitsugu Matsumoto, YasuyukiGoto. Hemophagocytosis in Experimental Visceral Leishmaniasis by Leishmania donovani. PLoS Negl Trop Dis. 2016 Mar; 10(3): e0004505.
- Bhatia P, Haldar D, Varma N, Marwaha R, Varma S. A case series highlighting the relative frequencies of the common, uncommon and atypical/unusual hematological findings on bone marrow examination in cases of visceral leishmaniasis. Mediterr J Hematol Infect Dis. 2011;3(1):e2011035.
- Chandra H, Chandra S, Kaushik RM. Visceral leishmaniasis with associated common, uncommon, and atypical morphological features on bone marrow aspirate cytology in nonendemic region. J Trop Med. 2013;2013:861032.
- Dhingra KK, Gupta P, Saroha V, Setia N, Khurana N, Singh T. Morphological findings in bone marrow biopsy and aspirate smears of visceral kala azar: A review. Indian J Pathol Microbiol 2010;53:96-100
- Cotterell SE, Engwerda CR, Kaye PM. Leishmania donovani infection of bone marrow stromal macrophages selectively enhances myelopoiesis, by a mechanism involving GM-CSF and TNF-alpha. Blood. 2000 Mar 1;95(5):1642-51.
- Chandra H, Chandra S, Bhat NK, Sharma A. Clinicohaematological profile of infections in bone marrow - single centre experience in North Himalayan region of India. Hematology. 2011 Jul;16(4):255-7.
- Kopterides P, Halikias S, Tsavaris N. Visceral leishmaniasis masquerading as myelodysplasia. Am J Hematol. 2003 Nov;74(3):198-9.
- Yarali N, Fisgin T, Duru F, Kara A. Myelodysplastic features in visceral leishmaniasis. Am J Hematol. 2002 Nov;71(3):191-5.
- S.N. Wickramasinghe,S.H. Abdalla, E.G. Kasili. Ultrastructure of bone marrow in patients with visceral leishmaniasis. J Clin Pathol 1987;40:267-275
- Varma N, Naseem S. Hematologic changes in visceral leishmaniasis/kala azar. Indian J Hematol Blood Transfus. 2010 Sep;26(3):78-82.
- Valent P, Orazi A, Steensma DP, Ebert BL, Haase D, Malcovati L, van de Loosdrecht AA, Haferlach T, Westers TM, Wells DA, Giagounidis A, Loken M, Orfao A, Lübbert M, Ganser A, Hofmann WK, Ogata K, Schanz J, Béné MC, Hoermann G, Sperr WR, Sotlar K, Bettelheim P, Stauder R, Pfeilstöcker M, Horny HP, Germing U, Greenberg P, Bennett JM. Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions. Oncotarget. 2017 Jul 5;8(43):73483-73500.